In this study, by detecting the expression and phosphorylation levels of its main subfamily proteins, we found that STC2 inhibited the proliferation of breast cancer cells and promoted the apoptosis of TNBC cells by inhibiting the phosphorylation of Akt and blocking the Akt-related signalling pathway. Here, STC2 is linked to breast carcinoma.